T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis

Halina Offner, George A. Hashim, Arthur Vandenbark

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

Encephalitogenic T cells specific for myelin basic protein share common Vβ8 peptide sequences in their T cell receptor (TCR) that can induce autoregulatory T cells and antibodies that prevent clinical signs of experimental autoimmune encephalomyelitis (EAE). It is not known, however, if TCR peptides can treat established disease. To test its therapeutic value, TCR-Vβ8-39-59 peptide was injected into rats with clinical signs of EAE. This treatment reduced disease severity and speeded recovery, apparently by boosting anti-Vβ8 T cells and antibodies raised naturally in response to encephalitogenic VβS+ T cells. These results demonstrate that synthetic TCR peptides can be used therapeutically, and implicate the TCR-Vβ8-39-59 sequence as a natural idiotope involved in EAE recovery. Similarly, human TCR peptides may be effective in enhancing natural regulation of autoreactive T cells that share common V genes.

Original languageEnglish (US)
Pages (from-to)430-432
Number of pages3
JournalScience
Volume251
Issue number4992
StatePublished - Jan 25 1991

Fingerprint

Encephalomyelitis
T-Cell Antigen Receptor
Homeostasis
Peptides
Autoimmune Experimental Encephalomyelitis
T-Lymphocytes
Therapeutics
Artificial Cells
Myelin Basic Protein
Antibodies
Genes

ASJC Scopus subject areas

  • General

Cite this

T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. / Offner, Halina; Hashim, George A.; Vandenbark, Arthur.

In: Science, Vol. 251, No. 4992, 25.01.1991, p. 430-432.

Research output: Contribution to journalArticle

@article{79fb9c0cabce4893a0979f26399084e5,
title = "T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis",
abstract = "Encephalitogenic T cells specific for myelin basic protein share common Vβ8 peptide sequences in their T cell receptor (TCR) that can induce autoregulatory T cells and antibodies that prevent clinical signs of experimental autoimmune encephalomyelitis (EAE). It is not known, however, if TCR peptides can treat established disease. To test its therapeutic value, TCR-Vβ8-39-59 peptide was injected into rats with clinical signs of EAE. This treatment reduced disease severity and speeded recovery, apparently by boosting anti-Vβ8 T cells and antibodies raised naturally in response to encephalitogenic VβS+ T cells. These results demonstrate that synthetic TCR peptides can be used therapeutically, and implicate the TCR-Vβ8-39-59 sequence as a natural idiotope involved in EAE recovery. Similarly, human TCR peptides may be effective in enhancing natural regulation of autoreactive T cells that share common V genes.",
author = "Halina Offner and Hashim, {George A.} and Arthur Vandenbark",
year = "1991",
month = "1",
day = "25",
language = "English (US)",
volume = "251",
pages = "430--432",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "4992",

}

TY - JOUR

T1 - T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis

AU - Offner, Halina

AU - Hashim, George A.

AU - Vandenbark, Arthur

PY - 1991/1/25

Y1 - 1991/1/25

N2 - Encephalitogenic T cells specific for myelin basic protein share common Vβ8 peptide sequences in their T cell receptor (TCR) that can induce autoregulatory T cells and antibodies that prevent clinical signs of experimental autoimmune encephalomyelitis (EAE). It is not known, however, if TCR peptides can treat established disease. To test its therapeutic value, TCR-Vβ8-39-59 peptide was injected into rats with clinical signs of EAE. This treatment reduced disease severity and speeded recovery, apparently by boosting anti-Vβ8 T cells and antibodies raised naturally in response to encephalitogenic VβS+ T cells. These results demonstrate that synthetic TCR peptides can be used therapeutically, and implicate the TCR-Vβ8-39-59 sequence as a natural idiotope involved in EAE recovery. Similarly, human TCR peptides may be effective in enhancing natural regulation of autoreactive T cells that share common V genes.

AB - Encephalitogenic T cells specific for myelin basic protein share common Vβ8 peptide sequences in their T cell receptor (TCR) that can induce autoregulatory T cells and antibodies that prevent clinical signs of experimental autoimmune encephalomyelitis (EAE). It is not known, however, if TCR peptides can treat established disease. To test its therapeutic value, TCR-Vβ8-39-59 peptide was injected into rats with clinical signs of EAE. This treatment reduced disease severity and speeded recovery, apparently by boosting anti-Vβ8 T cells and antibodies raised naturally in response to encephalitogenic VβS+ T cells. These results demonstrate that synthetic TCR peptides can be used therapeutically, and implicate the TCR-Vβ8-39-59 sequence as a natural idiotope involved in EAE recovery. Similarly, human TCR peptides may be effective in enhancing natural regulation of autoreactive T cells that share common V genes.

UR - http://www.scopus.com/inward/record.url?scp=0025969733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025969733&partnerID=8YFLogxK

M3 - Article

VL - 251

SP - 430

EP - 432

JO - Science

JF - Science

SN - 0036-8075

IS - 4992

ER -